satralizumab
satralizumab: 2 clinical trials tracked.
satralizumab evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
What is verified about satralizumab, and what remains unknown?
Traceable citations · Unknowns marked
Clinical Trial Registry Records (2)
A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab and Eculizumab To Prevent Relapses in Neuromyelitis Optica Spectrum Disorder
Primary endpoint: Time to adjudicated safety or tolerability failure
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Basket Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
Primary endpoint: Part 1: Proportion of Participants in NMDAR AIE Cohort With Modified Rankin Scale (mRS) Score Improvement ≥ 1 From Baseline and no Use of Rescue Therapy at Week 24